‘All Minds Matter’ aims to promote understanding, reduce stigma, and encourage open conversations about mental health
So far, the campaign focused on raising awareness about schizophrenia and is now broadening its scope to include Attention Deficit Hyperactivity Disorder (ADHD)
The campaign launched a powerful short film on ADHD, with the goal of reaching and educating the broader public through diverse real-life scenarios
Mumbai, India, November 21, 2023: The Janssen Pharmaceutical Companies of Johnson & Johnson is taking significant strides to extend its dedication to mental health awareness. Janssen India’s ‘All Minds Matter‘ a digital campaign across Instagram, Facebook and YouTube is aimed at helping individuals prioritize their mental health and enhance their quality of life by raising awareness about mental health issues. This campaign focussed specifically on schizophrenia and will now include Attention Deficit Hyperactivity Disorder (ADHD) in its comprehensive approach to promote mental health well-being.
Mental health issues continue to be a growing concern in India and worldwide, impacting the lives of countless individuals and their families. To shed light on the varying mental health issues and aimed at deciphering the profound gaps surrounding schizophrenia, the company launched the ‘All Minds Matter’ campaign in April 2022. The campaign diligently strove to drive awareness, initiate informed dialogues, and enhance the quality of life for patients and caregivers grappling with schizophrenia.
Bolstered by the success of the campaign in debunking stigmas and misconceptions around schizophrenia, the company is now extending its commitment to mental health by focusing on ADHD beginning with the launch of a powerful short film during ADHD Awareness Month in October. Although, initially regarded as a childhood condition, evidence states that ADHD, being a neurodevelopmental disorder, persists into adulthood although the symptoms may be somewhat modified with age.1 The film will portray diverse scenarios involving working professionals, parents, and teenagers, with the aim of reaching and educating the broader public through diverse real-life scenarios.
ADHD is recognized by attention deficit, hyperactivity, and impulsiveness and influences multiple facets of daily life, from education to relationships and work. According to several studies, globally less than 20% of adults suffering from ADHD are aware of their condition2, while in India, about 14% of the population is known to be battling ADHD3—a neurodevelopmental disorder profoundly affecting emotional well-being. Many affected by ADHD battle internal misconceptions, believing it’s an unfixable flaw, leading to untreated ADHD and a cycle of self-doubt.
With the powerful message of the campaign, ‘It’s not you; it could be ADHD,’ Janssen India aims to dispel misconceptions, extend support, and urge individuals to seek professional assistance.
“We are committed to fostering a society where mental health is accepted, understood, and supported, regardless of the specific condition. Extending our campaign to encompass ADHD is a natural evolution of our ongoing mission to eliminate stigma, raise awareness, and enhance the lives of individuals facing mental health challenges” said Dr. Jitendra Dixit, Head of Medical Affairs, Janssen India.
Janssen India’s commitment to mental health awareness remains steadfast, and the extension of ‘All Minds Matter’ to encompass ADHD demonstrates its ongoing mission to make a positive impact on the mental health landscape by providing valuable resources and information to support patients and their caregivers.
Janssen India is a Johnson & Johnson company, for more information on ‘All Minds Matter’ campaign and the resources available, please visit All Minds Matter on Instagram, Facebook, YouTube.
Link to the new film: here
